# EVOTAZ
> **NDA206353** · New Drug Application · Sponsor: BRISTOL · Approved 2015-01-29
## Drug
- **FDA Application Number:** NDA206353
- **Application type:** New Drug Application
- **Brand name:** EVOTAZ
- **Generic name:** ATAZANAVIR AND COBICISTAT
- **Active ingredients:** ATAZANAVIR SULFATE; COBICISTAT
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** BRISTOL
- **Manufacturer:** E.R. Squibb & Sons, L.L.C.
- **First approval:** 2015-01-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206353)
---
*AI Analytics · CC0 1.0*